Table 1

Clinicopathological features and the expression of SOX9 in 130
    hepatocellular carcinoma
patients
Clinicopathological Features Case SOX9 expression frequency (n,%) P
High Low
Age (years)
≤50 72 55 (76.39) 17 (23.61) NS
>50 58 43 (74.14) 15 (25.86)
Gender
Male 96 73 (76.04) 23 (23.96) NS
Female 34 25 (73.53) 9 (26.47)
Tumor stage
T1 23 8 (34.78) 15 (65.22) 0.03
T2 40 25 (62.50) 15 (37.50)
T3 52 50 (96.15) 2 (3.85)
T4 15 15 (100.00) 0 (0)
Tumor grade
G1 31 18 (58.01) 13 (41.99) 0.01
G2 76 58 (76.32) 18 (23.68)
G3 23 22 (95.65) 1 (4.35)
Growth pattern
Trabecular 101 78 (77.23) 23 (22.77) NS
Nontrabecular 29 20 (68.97) 9 (31.03)
Cirrhosis
Yes 86 62 (72.09) 24 (27.91) NS
No 44 36 (81.82) 8 (18.18)
Underlying liver disease
Alcoholic 25 18 (72.00) 7 (28.00) NS
Hepatitis B 49 40 (81.63) 9 (18.37)
Hepatitis C 35 28 (80.00) 7 (20.00)
Unknown 21 12 (57.14) 9 (42.86)

Guo et al.

Guo et al. Diagnostic Pathology 2012 7:44   doi:10.1186/1746-1596-7-44

Open Data